Journal of Neuroscience · 2003 · 63 citations · 34 references
MedicineNeurosciencePharmacologyNeuroendocrinologyNeuropharmacologyPain MedicineAnalgesiaPain MechanismsPain ModulationPain NeurobiologyPain NeurosciencePain PhysiologyEndogenous Opioid ModulationEndogenous Opioid SignalingNociceptive MechanismsNociceptive TransmissionOpioid Receptor AgonistsOpioid System ModulationPain PharmacologyPharmacological Pain Relief
Progress in the control and treatment of pain may be facilitated by a better understanding of mechanisms underlying nociceptive processing. Here we show that mice subjected to an intermittent fasting diet (IFD) display markedly reduced responses in models of thermal and visceral pain compared with mice fed ad libitum (AL). Pharmacological analyses suggest that a change in the endogenous kappa-opioid system underlies IFD-induced analgesia. The levels of prodynorphin mRNA and kappa-opioid receptors in the spinal cord are higher in IFD than in AL mice. Furthermore, in spinal cord nuclear protein extracts, the activity of the transcriptional repressor DREAM (downstream regulatory element antagonist modulator), the main regulator of prodynorphin expression, is lower in IFD than in AL mice. Finally, c-Fos expression in dorsal spinal cord after noxious stimulation is significantly lower in IFD than in AL animals, indicating that dynorphin could block nociceptive information at the spinal cord. These results suggest that dietary restriction together with administration of kappa-opioid agonists could be useful as a new therapeutic approach for pain relief.
34
R. Michael Anson, Zhihong Guo, Rafael de Cabo et al. · Proceedings of the National Academy of Sciences · 2003 · 733 citations
Primary afferent tachykinins are required to experience moderate to intense pain
Yu Cao, Patrick W. Mantyh, Elaine J. Carlson et al. · Nature · 1998 · 600 citations
DREAM is a Ca2+-regulated transcriptional repressor
Ángel Manuel Carrión, Wolfgang Link, Fran Ledo et al. · Nature · 1999 · 572 citations · Full text